斯堪的纳维亚宫颈筛查人群在引入HPV疫苗接种计划后HPV感染下降
该研究在丹麦、挪威和瑞典的宫颈筛查女性中比较四价HPV疫苗接种计划引入前后HPV感染率变化。2006-2008年纳入6538名女性,2012-2013年纳入6332名类似入组女性。结果显示总体HPV阳性率从36.5%略降至34.5%,18-26岁女性从54.4%降至48.1%(P<0.001),疫苗型HPV从22.3%降至16.6%(P<0.001),而27-50岁女性无变化(22.5% vs 21.6%)。
要点
- 18-26岁女性HPV阳性率从54.4%降至48.1%(P<0.001)。
- 疫苗型HPV6/11/16/18从22.3%降至16.6%(P<0.001)。
- 27-50岁女性HPV阳性率无变化(22.5% vs 21.6%)。
核心结论
- 在2008-2009年启动qHPV疫苗接种计划的丹麦和挪威,年轻人群HPV感染明显下降,提示有组织的HPV疫苗接种计划导致一般人群中循环的HPV型别减少。
研究设计与样本
- 基于人群的研究,在丹麦、挪威和瑞典的宫颈筛查项目中,分别于2006-2008年纳入6538名女性和2012-2013年纳入6332名类似入组女性,采集液基细胞学样本。
- 所有HPV检测和基因分型均采用相同的入组和分析方法,使用认证的通用引物聚合酶链反应方法,并通过Luminex系统进行分型。
主要发现
- 总体HPV阳性率从2006-2008年的36.5%略降至2012-2013年的34.5%。
- 18-26岁女性HPV阳性率从54.4%降至48.1%(P<0.001)。
- 疫苗型HPV6/11/16/18总体从22.3%降至16.6%(P<0.001);低危疫苗型HPV6/11从5.0%降至2.5%,高危疫苗型HPV16/18从18.9%降至14.9%。
- 27-50岁女性HPV阳性率在两个时间段之间无变化(22.5% vs 21.6%)。
- 年轻年龄组的显著下降在3个国家间存在差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To monitor the changes in prevalence of human papillomavirus (HPV) infections in women <50 years of age, participating in cervical screening programs of Denmark, Norway, and Sweden, before and after introduction of quadrivalent HPV (qHPV) vaccination. METHODS: Liquid-based cytology samples were collected from 6538 women who attended cervical screening in Denmark, Norway, and Sweden in 2006-2008 and from 6332 similarly enrolled women in 2012-2013. Denmark started organized qHPV vaccination in 2008, Norway in 2009, and Sweden in 2012. All HPV testing and genotyping was performed using identical enrollment and analysis methods, by accredited general primer polymerase chain reaction methods with typing using the Luminex system. RESULTS: Overall HPV positivity declined slightly from 36.5% in 2006-2008 to 34.5% in 2012-2013. The decline was most pronounced among women 18-26 years of age: from 54.4% to 48.1% (P < 0.001). The decline was substantial for vaccine HPV types (HPV6/11/16/18: decline from 22.3% to 16.6%; P < 0.001) and was seen for both low-risk vaccine types (HPV6/11 declined from 5.0% to 2.5%) and high-risk vaccine types (HPV16/18 declined from 18.9% to 14.9%). Among women 27-50 years of age, there was no change between the time periods (22.5% and 21.6%, respectively). The significant decline in the younger age group was different in the 3 countries. CONCLUSION: This population-based study enrolling >12,000 women participating in cervical screening in the 3 Nordic countries before and after introduction of organized qHPV vaccination demonstrated a marked decline in HPV infection in the younger population in the 2 countries where qHPV vaccination programs started in 2008-2009, suggesting that organized HPV vaccination programs resulted in a decrease of HPV types circulating in the general population.
引用
- Dillner J, Nygård M, Munk C, et al. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs. Vaccine. 2018. PMID: 29778519. doi:10.1016/j.vaccine.2018.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。